BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,557,202 | -52.9% | 522,129 | -37.5% | 0.00% | -66.7% |
Q2 2023 | $26,667,680 | +19.3% | 835,192 | +14.4% | 0.00% | +50.0% |
Q1 2023 | $22,356,520 | -11.9% | 730,128 | +12.5% | 0.00% | -33.3% |
Q4 2022 | $25,386,457 | +2.3% | 649,104 | +24.6% | 0.00% | 0.0% |
Q3 2022 | $24,825,000 | +6.3% | 521,120 | -13.6% | 0.00% | 0.0% |
Q2 2022 | $23,360,000 | -26.1% | 603,490 | +9.4% | 0.00% | -25.0% |
Q1 2022 | $31,599,000 | -16.7% | 551,466 | +15.8% | 0.00% | -20.0% |
Q4 2021 | $37,939,000 | -4.9% | 476,088 | +3.8% | 0.01% | 0.0% |
Q3 2021 | $39,904,000 | +2.8% | 458,624 | +52.0% | 0.01% | 0.0% |
Q2 2021 | $38,824,000 | +133.0% | 301,634 | +44.9% | 0.01% | +150.0% |
Q1 2021 | $16,664,000 | +264.0% | 208,195 | +271.3% | 0.00% | +100.0% |
Q4 2020 | $4,578,000 | +408.1% | 56,078 | +53.3% | 0.00% | – |
Q3 2020 | $901,000 | +55.6% | 36,591 | +76.8% | 0.00% | – |
Q2 2020 | $579,000 | +1830.0% | 20,700 | +1120.5% | 0.00% | – |
Q1 2020 | $30,000 | – | 1,696 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |